Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker contracted to make UK’s coronavirus jabs

ER Editor: We also recommend this May 2020 report by Vanessa Beeley detailing potential conflicts of interest for Vallance, Matt Hancock and Chris Witty – COVID–19: The Big Pharma players behind UK Government lockdown. Of note in relation to Vallance, who was head of R&D at GSK before entering government as an advisor:

While Vallance and the UK Government are favouring AstraZeneca — in partnership with Oxford University — to fast-track vaccine development, GSK is also in the race.

GSK is working in collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), “aimed at helping the global effort to develop a vaccine” for Covid–19. The UK Government has invested £50 million in CEPI to support the rapid vaccine and immunoprophylactic development against “unknown pathogens” (also referred to as Disease X). Bill Gates was one of the original and most influential sponsors of CEPI; more details later in this article.

So, the UK Government appears to favour AstraZeneca, but Vallance and the government also appear to be subtly supporting Vallance’s former employer, GSK, despite their Pandemrix fiasco.

While Vallance was in charge of research and development at GSK, collaboration with the Bill and Melinda Gates foundation was increased. In 2013, a new parnership between GSK and the Gates Foundation was announced: to “accelerate research into vaccines for global health needs”.

What we start to see here is the very definition of a revolving-door policy between philanthrocapitalism, Big Pharma and government agencies, all effectively working in lock-step to promote the global immunisation agenda, with massive projected profit for the Big Pharma complex …


Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker contracted to make UK’s coronavirus jabs


Sir Patrick Vallance has a £600,000 shareholding in a pharmaceuticals giant which is racing to develop a Covid vaccine for the Government, a report has revealed.

The Chief Scientific Adviser holds the deferred bonus of 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the multinational company.

Sir Patrick has already sold more than £5 million in shares he received during his tenure from 2012 to 2018, when he was appointed by the Government.

Accounts seen by the Telegraph show that Sir Patrick held 404,201 GSK shares when he resigned, worth £6.1 million at today’s price.

Sir Patrick, who also chairs the Government’s expert panel on vaccines, predicted at a news conference this week that the first effective doses of a jab might become available on a limited basis by the end of this year.

GSK is one of more than 20 drugs companies around the world in the race to provide the cure for coronavirus – an achievement which would be colossally lucrative.

Sir Patrick’s former employer has deals with the British and US governments to supply them with Covid-19 vaccines, subject to terms in a final contract.

A senior Conservative MP and ex-Cabinet minister told The Telegraph that Sir Patrick should have declared his stake in GSK.

‘The policy of this Government is to try to suppress Covid at every opportunity until we get a vaccine,’ the MP said.

‘That makes it more likely that a vaccine will be prioritised by the Government and he happens to be holding shares in one of the leading companies that are developing it. It is a potential conflict of interest.

‘If he is making decisions on vaccines and advising the Government on them, then he either needs to divest himself of the shares or make a declaration every time he touches on the subject. In the Commons, every time MPs raise an issue in which there is a registered interest, they have to declare it. Every time he is talking about vaccines or on TV, he should put it on the table.’

It was unclear if Sir Patrick did in fact declare his interest at any stage. MailOnline has contacted him seeking clarification.

The Government said that Sir Patrick holds a deferred share bonus which will mature in April 2021 but declined to comment on the size of the holding or its value.





The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.